Erythropoietin
Nonimmune Chronic Idiopathic Neutropenia Of Adults
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicoprotein_peptideUnknownActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Nonimmune Chronic Idiopathic Neutropenia Of Adults cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Luspatercept Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Unknown | D |
Fecal Microbiome Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Unknown | D |
Same molecule, other indications
Erythropoietin is also rated in:
disease related to hematopoietic stem cell transplantDormant
BB
Indicative · Phase 4
65 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →